AZN: Year-To-Date and Q3 2017 Results Announcement

Report this content

AstraZeneca PLC
9 November 2017 07:00

Year-To-Date and Q3 2017 Results
An improved sales performance as the pipeline-driven transformation gathered pace

Click on, or paste the following link into your web browser, to view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/9881V_1-2017-11-8.pdf

This information is provided by RNS
The company news service from the London Stock Exchange

END